Developing a multilocus genotyping scheme for Cryptosporidium parvum
Author(s): ,
Rachel Chalmers
Affiliations:
Public Health Wales
,
Guy Robinson
Affiliations:
Public Health Wales
Gregorio Pérez-Cordón
Affiliations:
Public Health Wales
PHE ePoster Library. Chalmers R. 03/20/18; 205892; 12512
Rachel Chalmers
Rachel Chalmers
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)
Abstract The zoonotic protozoan Cryptosporidium parvum causes around half of cryptosporidiosis cases in the UK. Sexual recombination drives genetic variation and merits a multilocus genotyping (MLG) approach to track sources of contamination and routes of transmission, and inform risk assessments and outbreak investigations. To encourage standardisation across countries and between laboratories with varying resources, we used whole genome sequencing to identify new variable numbers of tandem repeat markers, predicted to be suitable for fragment sizing by capillary electrophoresis. Seven of 28 markers identified initially in the C. parvum reference genome (Tandem Repeats Finder, New York) were selected on the basis of un-linked, simple tandem repeat motifs of ≥6 bp displying variable numbers in in-house genomes. Four were 6 bp motifs and the others 12, 15 and 27. PCR primers were designed and fragment sizes estimated for 20 C. parvum samples using a QIAxcel Advanced (Qiagen) machine, run under optimised conditions, and compared with sequencing. Estimated fragment sizes were confirmed in most samples. When repeatability and reproducibility was investigated using triplicate PCR reactions of four samples on two occasions, discrepancies were observed in a small number of reactions but were resolved readily. However, when applied to a larger validation panel of 269 C. parvum samples representing spatio-temporal variation, outbreaks and sporadic infections of humans and animals, 5% PCR reactions were not detectable, and a further 5% provided inconsistent and unresolvable ambiguous sizes especially in the 6 bp repeat markers. To improve accuracy and reliability, we re-evaluated the MLG scheme using labelled primers for fragment sizing on a different platform (3500 Genetic Analyzer, Applied Biosystems™). Multiplexing the PCRs provided an economic approach, and the sample archive held at the reference unit enabled full scale validation (typability, discriminatory power, epidemiological concordance and efficiency) of a MLG scheme for C. parvum. Funding EU Framework Seven 'Aquavalens'
Abstract The zoonotic protozoan Cryptosporidium parvum causes around half of cryptosporidiosis cases in the UK. Sexual recombination drives genetic variation and merits a multilocus genotyping (MLG) approach to track sources of contamination and routes of transmission, and inform risk assessments and outbreak investigations. To encourage standardisation across countries and between laboratories with varying resources, we used whole genome sequencing to identify new variable numbers of tandem repeat markers, predicted to be suitable for fragment sizing by capillary electrophoresis. Seven of 28 markers identified initially in the C. parvum reference genome (Tandem Repeats Finder, New York) were selected on the basis of un-linked, simple tandem repeat motifs of ≥6 bp displying variable numbers in in-house genomes. Four were 6 bp motifs and the others 12, 15 and 27. PCR primers were designed and fragment sizes estimated for 20 C. parvum samples using a QIAxcel Advanced (Qiagen) machine, run under optimised conditions, and compared with sequencing. Estimated fragment sizes were confirmed in most samples. When repeatability and reproducibility was investigated using triplicate PCR reactions of four samples on two occasions, discrepancies were observed in a small number of reactions but were resolved readily. However, when applied to a larger validation panel of 269 C. parvum samples representing spatio-temporal variation, outbreaks and sporadic infections of humans and animals, 5% PCR reactions were not detectable, and a further 5% provided inconsistent and unresolvable ambiguous sizes especially in the 6 bp repeat markers. To improve accuracy and reliability, we re-evaluated the MLG scheme using labelled primers for fragment sizing on a different platform (3500 Genetic Analyzer, Applied Biosystems™). Multiplexing the PCRs provided an economic approach, and the sample archive held at the reference unit enabled full scale validation (typability, discriminatory power, epidemiological concordance and efficiency) of a MLG scheme for C. parvum. Funding EU Framework Seven 'Aquavalens'
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings